The "Storage" mitochondrial Model of Aging
1Andrei Panferov
1. Glycogen accumulation in long-lived C. elegans Source
Long-lived daf-2 mutants accumulate large glycogen stores, which initially appears consistent with the storage model. However, reducing glycogen synthesis through gsy-1 does not abolish their longevity. Glycogen appears to improve resistance to starvation and hyperosmotic stress, but it is not required for lifespan extension. Storage can therefore be an adaptive side effect rather than the primary cause of aging.
2. Late-life DAF-2 inhibition in old nematodes Source
Late degradation of DAF-2 in old C. elegans can extend remaining lifespan and restore the removal of some endogenous protein aggregates. This supports a moderate version of the model: aged cells retain latent capacities for proteostasis that can be reactivated. However, the intervention does not reverse all senescent pathologies or remove every class of aggregate. Cellular rejuvenation is selective rather than complete.
3. Increasing mitochondrial fission in middle-aged flies Source
Transient activation of Drp1-dependent mitochondrial fission in middle-aged Drosophila improves mitophagy, proteostasis, mitochondrial function, and lifespan. This supports the idea that age-related decline is partly reversible through improved quality control. However, it does not show that mitochondria deliberately create intracellular stores or that secretion of stored proteins is the central rejuvenation mechanism.
4. Decreasing mitochondrial fission in nematodes Source
In long-lived daf-2 nematodes, disruption of drp-1 can also extend lifespan and increase mitophagy. This is important because the beneficial intervention is directionally opposite to the fly experiment. There is no simple universal rule that aging is solved by either increasing or decreasing mitochondrial fission. The optimal intervention depends on the organism, tissue, developmental timing, and metabolic state.
5. Remofuscin and lipofuscin in nematodes Source
Remofuscin reduces lipofuscin-associated fluorescence and extends lifespan in C. elegans. However, the reported mechanism involves lysosome-to-nucleus signalling and activation of xenobiotic detoxification pathways. This makes lipofuscin an interesting therapeutic target, but it does not demonstrate that lipofuscin is a useful protein reserve that the cell later consumes to restore its identity.
6. Lipofuscin removal in mouse retina Source
In a mouse model of advanced Stargardt disease, removal of retinal pigment epithelium lipofuscin after a single intravitreal injection of Remofuscin reduces retinal degeneration and ameliorates retinal dysfunction. This is a strong local proof of concept: lipofuscin can be pathogenic, and its removal can rescue tissue function. However, the result fits the conventional interpretation of lipofuscin as harmful waste at least as well as the interpretation of lipofuscin as a deliberately preserved resource.
The available evidence is compatible with a weaker and scientifically useful claim: part of aging is maintained by reversible changes in proteostasis, lysosomal function, mitophagy, and resource allocation. Reactivating these systems can restore some functions even in old organisms.
The stronger claim remains unproven: that mitochondria deliberately “can” their host by accumulating intracellular stores, that the same mechanism explains every age-related disease, and that releasing those stores would restore all tissues across all organisms. Existing results already suggest multiple interacting mechanisms, selective reversibility, and strong context dependence.
A particularly clean test could use the reversible caste transition in Harpegnathos saltator: worker → long-lived gamergate → revertant worker. The same adult organism can move between short-lived and long-lived physiological states without changing its genome or passing through development again. Gamergates live approximately five times longer than workers, while revertants return to a worker-like lifespan.
Background sources:
https://doi.org/10.1126/science.abm8767
https://doi.org/10.1098/rspb.2021.0141
https://doi.org/10.21769/BioProtoc.4770
The experiment should measure lipofuscin, defined protein aggregates, lipid droplets, glycogen, lysosomal pH, autophagic flux, lysosomal exocytosis, and mitochondrial fission–fusion dynamics at several points before, during, and after the transition. These measurements should be paired with functional readouts in muscle, fat body, gut, and brain.
The storage model makes a falsifiable prediction: conversion to the long-lived gamergate state should produce a measurable reduction, export, or redistribution of the proposed intracellular stores before tissue function improves. Blocking the relevant clearance or secretion pathway should prevent rejuvenation and reduce the longevity benefit. After reversion to the worker state, the same stores should begin accumulating again. If lifespan changes substantially without the predicted movement of stored material, the model would require major revision.
The strongest version of the storage model makes an unusually broad prediction: the same intervention should restore function across different tissues and across evolutionarily distant organisms. A decisive experiment should therefore test the same candidate treatment in at least two distant species, for example C. elegans and aged mice, using the same predefined panel of intracellular “stores”: lipofuscin, selected protein aggregates, lipid droplets, glycogen, lysosomal pH, autophagic flux, lysosomal exocytosis, and mitochondrial dynamics.
The model predicts a conserved causal sequence: first, a measurable reduction, export, or redistribution of the proposed stored material; second, recovery of tissue-specific function; third, extension of healthy lifespan. The same sequence should appear in multiple tissues and in both species. Blocking the relevant clearance or secretion pathway should abolish the functional benefit.
This design would distinguish the storage model from a more conventional view in which proteostasis, lysosomal function, and mitochondrial quality control contribute to aging in a tissue-specific and context-dependent manner. If the same intervention clears the same classes of stores and restores function across distant species, the model gains substantial support. If the effects differ strongly by tissue or organism, or if function improves without movement of the proposed stored material, the universal version of the model would be weakened.
There is no need to treat every individual disease associated with aging. Curing just one is sufficient. The underlying molecular mechanism is identical for every disease. If a substance—or a combination of substances—exists that is capable of fully restoring the function of aged tissue, then that substance (or combination) will be effective in other tissues as well. In all likelihood, it will be effective in *all* tissues, across *all* organisms.
To put it in very simplistic—yet quasi-scientific—terms:
Mitochondria yearn to escape to the outside world; they once lived there, outside the cell, but they can no longer do so.
Consequently, the mitochondria decided to safeguard themselves—after all, there is no food out there.
Therefore, much like any other living creature, the mitochondria begin to stockpile resources: fats (lipid inclusions), carbohydrates (glycogen), and proteins. The situation with proteins proved particularly interesting: if a protein is merely inactivated, the cell will destroy it. However, if the protein is simply misfolded—or, conversely, if multiple proteins are clumped together into aggregates—then, technically speaking, the proteins still exist (and their potential function remains), so the cell decides to hold onto them; yet, in reality, they perform their duties very poorly.
This entire phenomenon has been variously termed "excessive differentiation" or "senescence."
But, in essence, the mitochondria are effectively "canning" their own "host."
Depending on the specific tissue, the particular set of proteins involved varies; consequently, the tissue's function differs, and any functional impairment manifests as a distinct disease.
Yet the root cause remains the same: accumulation...
One must spend—not hoard...
On the macro level:
The procurement and storage of proteins—or meat—entails solving a multitude of technical challenges; for instance, one needs a refrigerator. Alternatively, the proteins must be dried, cured, or otherwise processed to ensure long-term preservation.
It is far simpler to store livestock—whole and alive. They walk around and look after themselves. The main thing is that they keep walking—or, ideally, just stand still—but under no circumstances should they start running. For at that point, it ceases to be animal husbandry and becomes hunting instead. Livestock stands still, and is subsequently consumed as needed.
At the micro-level:
Mitochondria inhibit protein functions and stimulate their accumulation.
The "livestock" stands still—it does not run around the cell—and is consumed as it becomes ready and as necessity dictates.
Each tissue harbors a distinct "breed" of these "cows," manifesting in unique functional impairments and specific pathologies.
There is a vast body of literature documenting mitochondrial fission in aging tissues.
Lipofuscin: it is ubiquitous—appearing in virtually every publication and every review article. Lipofuscin acts as a massive "canning jar," maintained at a specific pH level—slightly above 5.0—that prevents both enzymatic digestion and spoilage.
If the secretion of these "stockpiled"—and partially "preserved"—proteins is induced, the cell "recollects" its original functions, resulting in a restoration of its somatic identity.
Sergei Vatolin